A potential next generation sclerostin inhibitor specifically targets sclerostin monomer for bone anabolic therapy with low ardiovascular risk in osteogenesis imperfecta mice (Abstract)

Qing Ren; Duoli Xie; Yuanyuan Yu; Yuan Tang; Shuaijian Ni; Jun Lu; Aiping Lu; Ge Zhang; Sum Yee  Chan; Bao Ting Zhang

doi:10.1002/jbmr.3936

A potential next generation sclerostin inhibitor specifically targets sclerostin monomer for bone anabolic therapy with low ardiovascular risk in osteogenesis imperfecta mice (Abstract)

Qing Ren
, Duoli Xie
, Yuanyuan Yu
, Yuan Tang
, Shuaijian Ni
, Jun Lu
, Aiping Lu
, Ge Zhang
, Sum Yee Chan
, Bao Ting Zhang

Research output: Contribution to journal › Conference article › peer-review

Original language	English
Pages (from-to)	47-48
Number of pages	2
Journal	Journal of Bone and Mineral Research
Volume	34
Issue number	S1
DOIs	https://doi.org/10.1002/jbmr.3936
Publication status	Published - Dec 2019
Event	2019 Annual Meeting of the American Society for Bone and Mineral Research, ASBMR 2019 - Orange County Convention Center, Orlando, United States Duration: 20 Sept 2019 → 23 Sept 2019 https://onlinelibrary.wiley.com/doi/abs/10.1002/jbmr.3936 (Conference abstract (Wiley)) https://academic.oup.com/jbmr/issue/34/S1 (Conference abstract (OUP))

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1002/jbmr.3936

Cite this

Ren, Q., Xie, D., Yu, Y., Tang, Y., Ni, S., Lu, J., Lu, A., Zhang, G., Chan, S. Y., & Zhang, B. T. (2019). A potential next generation sclerostin inhibitor specifically targets sclerostin monomer for bone anabolic therapy with low ardiovascular risk in osteogenesis imperfecta mice (Abstract). Journal of Bone and Mineral Research, 34(S1), 47-48. https://doi.org/10.1002/jbmr.3936

@article{2023cdb2c9aa41949915b0ea91e3d1e0,

title = "A potential next generation sclerostin inhibitor specifically targets sclerostin monomer for bone anabolic therapy with low ardiovascular risk in osteogenesis imperfecta mice (Abstract)",

author = "Qing Ren and Duoli Xie and Yuanyuan Yu and Yuan Tang and Shuaijian Ni and Jun Lu and Aiping Lu and Ge Zhang and Chan, \{Sum Yee\} and Zhang, \{Bao Ting\}",

year = "2019",

month = dec,

doi = "10.1002/jbmr.3936",

language = "English",

volume = "34",

pages = "47--48",

journal = "Journal of Bone and Mineral Research",

issn = "0884-0431",

publisher = "Oxford University Press",

number = "S1",

note = "2019 Annual Meeting of the American Society for Bone and Mineral Research, ASBMR 2019 ; Conference date: 20-09-2019 Through 23-09-2019",

url = "https://onlinelibrary.wiley.com/doi/abs/10.1002/jbmr.3936, https://academic.oup.com/jbmr/issue/34/S1",

}

Ren, Q, Xie, D, Yu, Y, Tang, Y, Ni, S, Lu, J, Lu, A , Zhang, G, Chan, SY & Zhang, BT 2019, 'A potential next generation sclerostin inhibitor specifically targets sclerostin monomer for bone anabolic therapy with low ardiovascular risk in osteogenesis imperfecta mice (Abstract)', Journal of Bone and Mineral Research, vol. 34, no. S1, pp. 47-48. https://doi.org/10.1002/jbmr.3936

A potential next generation sclerostin inhibitor specifically targets sclerostin monomer for bone anabolic therapy with low ardiovascular risk in osteogenesis imperfecta mice (Abstract). / Ren, Qing; Xie, Duoli; Yu, Yuanyuan et al.
In: Journal of Bone and Mineral Research, Vol. 34, No. S1, 12.2019, p. 47-48.

Research output: Contribution to journal › Conference article › peer-review

TY - JOUR

T1 - A potential next generation sclerostin inhibitor specifically targets sclerostin monomer for bone anabolic therapy with low ardiovascular risk in osteogenesis imperfecta mice (Abstract)

AU - Ren, Qing

AU - Xie, Duoli

AU - Yu, Yuanyuan

AU - Tang, Yuan

AU - Ni, Shuaijian

AU - Lu, Jun

AU - Lu, Aiping

AU - Zhang, Ge

AU - Chan, Sum Yee

AU - Zhang, Bao Ting

PY - 2019/12

Y1 - 2019/12

U2 - 10.1002/jbmr.3936

DO - 10.1002/jbmr.3936

M3 - Conference article

SN - 0884-0431

VL - 34

SP - 47

EP - 48

JO - Journal of Bone and Mineral Research

JF - Journal of Bone and Mineral Research

IS - S1

T2 - 2019 Annual Meeting of the American Society for Bone and Mineral Research, ASBMR 2019

Y2 - 20 September 2019 through 23 September 2019

ER -